The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways.

Ovarian cancers migrate and metastasize over the surface of the peritoneal cavity. Consequently, dysregulation of mechanisms that limit cell migration may be particularly important in the pathogenesis of the disease. ARHI is an imprinted tumor-suppressor gene that is downregulated in >60% of...

Full description

Bibliographic Details
Main Authors: Badgwell, D, Lu, Z, Le, K, Gao, F, Yang, M, Suh, G, Bao, J, Das, P, Andreeff, M, Chen, W, Yu, Y, Ahmed, A, S-L Liao, W, Bast, R
Format: Journal article
Language:English
Published: 2012
_version_ 1797059315496910848
author Badgwell, D
Lu, Z
Le, K
Gao, F
Yang, M
Suh, G
Bao, J
Das, P
Andreeff, M
Chen, W
Yu, Y
Ahmed, A
S-L Liao, W
Bast, R
author_facet Badgwell, D
Lu, Z
Le, K
Gao, F
Yang, M
Suh, G
Bao, J
Das, P
Andreeff, M
Chen, W
Yu, Y
Ahmed, A
S-L Liao, W
Bast, R
author_sort Badgwell, D
collection OXFORD
description Ovarian cancers migrate and metastasize over the surface of the peritoneal cavity. Consequently, dysregulation of mechanisms that limit cell migration may be particularly important in the pathogenesis of the disease. ARHI is an imprinted tumor-suppressor gene that is downregulated in >60% of ovarian cancers, and its loss is associated with decreased progression-free survival. ARHI encodes a 26-kDa GTPase with homology to Ras. In contrast to Ras, ARHI inhibits cell growth, but whether it also regulates cell motility has not been studied previously. Here we report that re-expression of ARHI decreases the motility of IL-6- and epidermal growth factor (EGF)-stimulated SKOv3 and Hey ovarian cancer cells, inhibiting both chemotaxis and haptotaxis. ARHI binds to and sequesters Stat3 in the cytoplasm, preventing its translocation to the nucleus and localization in focal adhesion complexes. Stat3 siRNA or the JAK2 inhibitor AG490 produced similar inhibition of motility. However, the combination of ARHI expression with Stat3 knockdown or inhibition produced greatest inhibition in ovarian cancer cell migration, consistent with Stat3-dependent and Stat3-independent mechanisms. Consistent with two distinct signaling pathways, knockdown of Stat3 selectively inhibited IL-6-stimulated migration, whereas knockdown of focal adhesion kinase (FAK) preferentially inhibited EGF-stimulated migration. In EGF-stimulated ovarian cancer cells, re-expression of ARHI inhibited FAK(Y397) and Src(Y416) phosphorylation, disrupted focal adhesions, and blocked FAK-mediated RhoA signaling, resulting in decreased levels of GTP-RhoA. Re-expression of ARHI also disrupted the formation of actin stress fibers in a FAK- and RhoA-dependent manner. Thus, ARHI has a critical and previously uncharacterized role in the regulation of ovarian cancer cell migration, exerting inhibitory effects on two distinct signaling pathways.
first_indexed 2024-03-06T20:02:28Z
format Journal article
id oxford-uuid:27c7d59c-28c6-493e-9273-d14f3bcafc64
institution University of Oxford
language English
last_indexed 2024-03-06T20:02:28Z
publishDate 2012
record_format dspace
spelling oxford-uuid:27c7d59c-28c6-493e-9273-d14f3bcafc642022-03-26T12:08:58ZThe tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:27c7d59c-28c6-493e-9273-d14f3bcafc64EnglishSymplectic Elements at Oxford2012Badgwell, DLu, ZLe, KGao, FYang, MSuh, GBao, JDas, PAndreeff, MChen, WYu, YAhmed, AS-L Liao, WBast, ROvarian cancers migrate and metastasize over the surface of the peritoneal cavity. Consequently, dysregulation of mechanisms that limit cell migration may be particularly important in the pathogenesis of the disease. ARHI is an imprinted tumor-suppressor gene that is downregulated in >60% of ovarian cancers, and its loss is associated with decreased progression-free survival. ARHI encodes a 26-kDa GTPase with homology to Ras. In contrast to Ras, ARHI inhibits cell growth, but whether it also regulates cell motility has not been studied previously. Here we report that re-expression of ARHI decreases the motility of IL-6- and epidermal growth factor (EGF)-stimulated SKOv3 and Hey ovarian cancer cells, inhibiting both chemotaxis and haptotaxis. ARHI binds to and sequesters Stat3 in the cytoplasm, preventing its translocation to the nucleus and localization in focal adhesion complexes. Stat3 siRNA or the JAK2 inhibitor AG490 produced similar inhibition of motility. However, the combination of ARHI expression with Stat3 knockdown or inhibition produced greatest inhibition in ovarian cancer cell migration, consistent with Stat3-dependent and Stat3-independent mechanisms. Consistent with two distinct signaling pathways, knockdown of Stat3 selectively inhibited IL-6-stimulated migration, whereas knockdown of focal adhesion kinase (FAK) preferentially inhibited EGF-stimulated migration. In EGF-stimulated ovarian cancer cells, re-expression of ARHI inhibited FAK(Y397) and Src(Y416) phosphorylation, disrupted focal adhesions, and blocked FAK-mediated RhoA signaling, resulting in decreased levels of GTP-RhoA. Re-expression of ARHI also disrupted the formation of actin stress fibers in a FAK- and RhoA-dependent manner. Thus, ARHI has a critical and previously uncharacterized role in the regulation of ovarian cancer cell migration, exerting inhibitory effects on two distinct signaling pathways.
spellingShingle Badgwell, D
Lu, Z
Le, K
Gao, F
Yang, M
Suh, G
Bao, J
Das, P
Andreeff, M
Chen, W
Yu, Y
Ahmed, A
S-L Liao, W
Bast, R
The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways.
title The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways.
title_full The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways.
title_fullStr The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways.
title_full_unstemmed The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways.
title_short The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways.
title_sort tumor suppressor gene arhi diras3 suppresses ovarian cancer cell migration through inhibition of the stat3 and fak rho signaling pathways
work_keys_str_mv AT badgwelld thetumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT luz thetumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT lek thetumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT gaof thetumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT yangm thetumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT suhg thetumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT baoj thetumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT dasp thetumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT andreeffm thetumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT chenw thetumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT yuy thetumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT ahmeda thetumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT slliaow thetumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT bastr thetumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT badgwelld tumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT luz tumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT lek tumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT gaof tumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT yangm tumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT suhg tumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT baoj tumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT dasp tumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT andreeffm tumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT chenw tumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT yuy tumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT ahmeda tumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT slliaow tumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways
AT bastr tumorsuppressorgenearhidiras3suppressesovariancancercellmigrationthroughinhibitionofthestat3andfakrhosignalingpathways